RESPONSIBLE PROVIDER IN ACCORDANCE WITH § 5 OF THE GERMAN TELEMEDIA ACT (TMG)

MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Telephone: +49 89 899 27-0
Fax: +49 89 899 27-222
Email: info@morphosys.com

 

RESPONSIBLE IN ACCORDANCE WITH § 18 PARA 2 OF THE GERMAN INTERSTATE TREATY ON BROADCASTING [MEDIENSTAATSVERTRAG – MSTV]

Dr. Malte Peters (CR&DO)
MorphoSys AG

 

MANAGEMENT BOARD

Dr. Jean-Paul Kress (Chairman, CEO), Sung Lee (CFO), Dr. Malte Peters (CR&DO)

 

CHAIRMAN OF THE SUPERVISORY BOARD 

Dr. Marc Cluzel

 

COMMERCIAL REGISTER

District Court of Munich, HRB 121023

 

VAT ID NO.

DE 155069821

 

REGULATORY AUTHORITY 

Government of Upper Bavaria 

 

REGISTERED TRADEMARKS 

HuCAL^®, HuCAL GOLD^®, HuCAL PLATINUM^®, CysDisplay^®, RapMAT^®, Ylanthia^®, 100 billion high potentials^®, Slonomics^®, CyCAT^®, and Monjuvi^®/Minjuvi^® are trademarks of the MorphoSys Group. Tremfya^® is a trademark of Janssen Biotech, Inc. XmAb^® is a trademark of Xencor, Inc.

 

DESIGN & PROGRAMMING

Digitas Pixelpark
www.digitaspixelpark.com

 

For better understandability, the use of male and female language forms is avoided. All personal descriptions apply equally to all genders.